Hilde Langseth
- Cancer Research top 5%
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 12
- Carcinogens and Genotoxicity Assessment 7
-
- Toxic Organic Pollutants Impact 6
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 10
- Oncology top 10%
- Cancer Risks and Factors 7
-
- Circular RNAs in diseases 5
-
- Occupational and environmental lung diseases 6
- Co-authors
- Anette HjartåkerRandi E. GislefossElisabete WeiderpassFreddie BrayBjarte AagnesInger Kristin LarsenAndreas KellerEckart Meese
- Journals
- International Journal of Cancer (6 papers)RNA Biology (5 papers)Cancer Epidemiology Biomarkers & Prevention (4 papers)
- Partner nations
- NorwayUnited StatesGermany
In The Last Decade
Hilde Langseth
60 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 561
- Health, Toxicology and Mutagenesis 212
- Reproductive Medicine 129
- Oncology 371
- Molecular Biology 545
Countries citing papers authored by Hilde Langseth
This map shows the geographic impact of Hilde Langseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Langseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Langseth more than expected).
Fields of papers citing papers by Hilde Langseth
This network shows the impact of papers produced by Hilde Langseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Langseth. The network helps show where Hilde Langseth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hilde Langseth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 3 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 40 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 103 | |
| 17 | 2016 | 32 | |
| 18 | 2015 | 15 | |
| 19 | 2015 | 32 | |
| 20 | 2013 | 25 |
About Hilde Langseth
Hilde Langseth is a scholar working on Cancer Research, Reproductive Medicine, Health, Toxicology and Mutagenesis, Otorhinolaryngology and Oncology, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (12 papers), Ovarian cancer diagnosis and treatment (10 papers), Cancer Risks and Factors (7 papers), Carcinogens and Genotoxicity Assessment (7 papers), Toxic Organic Pollutants Impact (6 papers), Occupational and environmental lung diseases (6 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (561 citations), Health, Toxicology and Mutagenesis (212 citations), Reproductive Medicine (129 citations), Oncology (371 citations) and Molecular Biology (545 citations). Hilde Langseth has collaborated with scholars based in Norway, United States and Germany. Frequent co-authors include Anette Hjartåker, Randi E. Gislefoss, Elisabete Weiderpass, Freddie Bray, Bjarte Aagnes, Inger Kristin Larsen, Andreas Keller, Eckart Meese, Aage Andersen and Trude Eid Robsahm. Their work appears in journals such as International Journal of Cancer, RNA Biology, Cancer Epidemiology Biomarkers & Prevention, Environmental Health Perspectives and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.